Schedule of warrants vested and outstanding |
Warrants vested and outstanding as of June 30, 2021 are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Source |
|
Exercise Price |
|
Term (Years) |
|
Number of Warrants Vested and Outstanding |
Pre 2015 Common Stock Warrants |
|
$ |
1.00 |
|
|
6-10 |
|
1,110,000 |
|
2015 Common Stock Warrants |
|
$ |
5.00 |
|
|
10 |
|
100,000 |
|
2016 Common Stock Warrants to Service Providers |
|
$ |
1.15 |
|
|
10 |
|
40,000 |
|
2016 Series C Common Stock Warrants to Placement Agent |
|
$ |
0.40 |
|
|
5 |
|
125,000 |
|
2017 Series D Common Stock Warrants to Placement Agent |
|
$ |
0.25 |
|
|
5 |
|
480,000 |
|
2017 Common Stock Warrants to Service Provider |
|
$ |
0.41 |
|
|
5 |
|
125,000 |
|
2018 Emerald Financing Warrants |
|
$ |
0.10 |
|
|
5 |
|
3,400,000 |
|
Emerald Multi-Draw Credit Agreement Warrants |
|
$ |
0.50 |
|
|
5 |
|
7,500,000 |
|
2019 Common Stock Warrants |
|
$ |
0.35 |
|
|
5 |
|
8,000,000 |
|
2020 Common Stock Warrants |
|
$ |
0.06 |
|
|
5 |
|
21,166,667 |
|
2020 Common Stock Warrants to Placement Agent |
|
$ |
0.075 |
|
|
4.99 |
|
8,166,667 |
|
Total warrants vested and outstanding as of June 30, 2021 |
|
|
|
|
|
50,213,334
|
|
|
Schedule of the activity of derivative liabilities |
The following tables summarize the activity of derivative liabilities for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, 2021 |
|
December 31, 2020
Fair
Value of Derivative Liabilities
|
|
Fair Value of Derivative Liabilities Issued |
|
Change in Fair Value of Derivative Liabilities |
|
Reclassification of Derivatives to Equity |
|
June 30, 2021
Fair
Value of Derivative Liabilities
|
Emerald Financing - warrant liability (1)
|
$ |
38,567 |
|
|
$ |
— |
|
|
$ |
358,998 |
|
|
$ |
— |
|
|
$ |
397,565 |
|
Current balance of derivative liabilities |
$ |
38,567
|
|
|
$ |
—
|
|
|
$ |
358,998
|
|
|
$ |
—
|
|
|
$ |
397,565
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, 2020 |
|
December 31, 2019
Fair
Value of Derivative Liabilities
|
|
Fair Value of Derivative Liabilities Issued |
|
Change in Fair Value of Derivative Liabilities |
|
Reclassification of Derivatives to Equity |
|
June 30, 2020
Fair
Value of Derivative Liabilities
|
Emerald Multi Draw Credit Agreement - compound derivative liability (2)
|
$ |
90,797 |
|
|
$ |
— |
|
|
$ |
(90,797) |
|
|
$ |
— |
|
|
$ |
— |
|
Emerald Financing - warrant liability (1)
|
276,024 |
|
|
— |
|
|
76,708 |
|
|
— |
|
|
352,732 |
|
Series B - warrant liability(3)
|
134,579 |
|
|
— |
|
|
4,539 |
|
|
(26,563) |
|
|
112,555 |
|
Total derivative liabilities |
$ |
501,400
|
|
|
$ |
—
|
|
|
$ |
(9,550) |
|
|
$ |
(26,563) |
|
|
$ |
465,287
|
|
Less, noncurrent portion of derivative liabilities |
(90,797) |
|
|
|
|
|
|
|
|
— |
|
Current balance of derivative liabilities |
$ |
410,603
|
|
|
|
|
|
|
|
|
$ |
465,287
|
|
Emerald Financing Warrant Liability (1) In connection with the August 2020 Financing, the exercise price of the warrants was permanently set to $0.10. The warrants contain a contingent put option if the Company undergoes a subsequent financing that results in a change in control. The warrant holders also have the right to participate in subsequent financing transactions on an as-if converted basis.
|
Schedule of input and valuation technique used to value warrant liabilities |
The warrant liability is valued at the balance sheet dates using the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2021 |
|
December 31, 2020 |
Dividend yield |
0.00% |
|
0.00% |
Volatility factor |
145.3% |
|
90.9% |
Risk-free interest rate |
0.18% |
|
0.14% |
Expected term (years) |
1.63 |
|
2.13 |
Underlying common stock price |
$0.16 |
|
$0.04 |
To compute the fair value of the warrants, the Company utilized the following assumptions in the Black Scholes Merton Option Pricing Model as follows:
|
|
|
|
|
|
|
June 30, 2020 |
Dividend yield |
0.00% |
Volatility factor |
104.9% |
Risk-free interest rate |
0.16% |
Expected term (years) |
0.14 |
Underlying common stock price |
$0.16 |
|